Additionally, SHP-1 deficiency in prostate cancer resulted in p27 accumulation, CDK6 reduction, retinoblastoma protein hypophosphorylation, cyclin E-CDK2 inhibition, and cycle arrest in phase G1 [86]. The gene discussed is NR0B2; the disease is prostate carcinoma.